Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 793–816 of 26,651 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CTRL Clear all

Conditions: Axial Spondyloarthrithis, Ankylosing Spondylitis
Interventions: Certolizumab Pegol, Placebo; Biological · Other
Lead sponsor: UCB BIOSCIENCES GmbH; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 736 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 16
States / cities: Glendale, Arizona • Mesa, Arizona • Phoenix, Arizona + 13 more

Conditions: Alzheimer's Disease
Interventions: MEM 3454; Drug
Lead sponsor: Memory Pharmaceuticals; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 7
States / cities: Phoenix, Arizona • Glendale, California • Atlanta, Georgia + 3 more

Conditions: Alopecia, Androgenetic
Interventions: TDM-105795, 0.0025%, TDM-105795, 0.02%, TDM-105795 topical vehicle solution; Drug
Lead sponsor: Technoderma Medicines Inc.; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 13
States / cities: North Little Rock, Arkansas • Rolling Meadows, Illinois • Plainfield, Indiana + 10 more

Conditions: Dental Plaque, Gingivitis
Interventions: Stannous Fluoride Toothpaste (Parodontax Complete Protection Toothpaste), CPC Mouthwash (Parodontax Active Gum Health Mouthwash), Regular Fluoride Toothpaste (Crest Cavity Protection); Drug
Lead sponsor: HALEON; Industry
Eligibility: 18 Years and older
Enrollment: 199 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Fort Wayne, Indiana

Conditions: Healthy
Interventions: wheat bran extract, control wheat bran extract; Other
Lead sponsor: Kellogg Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Glen Ellyn, Illinois

Conditions: Agitation Associated With Bipolar Disorder, Agitation,Psychomotor, Bipolar Disorder
Interventions: Sublingual film containing Dexmedetomidine (BXCL501), Placebo Film; Drug
Lead sponsor: BioXcel Therapeutics Inc; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 380 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 15
States / cities: Little Rock, Arkansas • Cerritos, California • Culver City, California + 12 more

Conditions: Macular Edema, Branch Retinal Vein Occlusion
Interventions: Faricimab, Aflibercept, Sham Procedure; Drug · Procedure
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 553 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 39
States / cities: Phoenix, Arizona • Tucson, Arizona • Campbell, California + 36 more

Conditions: Degenerative Disc Disease
Interventions: Rexlemestrocel-L + HA mixture, Saline; Drug
Lead sponsor: Mesoblast, Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 40
States / cities: Phoenix, Arizona • Tucson, Arizona • Chula Vista, California + 37 more

Conditions: Rosacea
Interventions: B244, Vehicle; Biological
Lead sponsor: AOBiome LLC; Industry
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 9
States / cities: Clearwater, Florida • Miami, Florida • Miramar, Florida + 4 more

Conditions: Respiratory Distress Syndrome, Adult
Interventions: BIO-11006, Placebo; Drug
Lead sponsor: BioMarck Pharmaceuticals, Ltd.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 5
States / cities: Chicago, Illinois • Chapel Hill, North Carolina • Winston-Salem, North Carolina + 2 more

Conditions: PTSD, Acute Stress Disorder, Trauma-related Stressor
Interventions: Placebo, Hydrocortisone; Drug
Lead sponsor: Rachel Yehuda; Other
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: New York, New York

Conditions: Asthma
Interventions: Lebrikizumab, Placebo, Inhaled corticposteroids (ICS), Second Asthma Controller Medication; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 16
States / cities: Tucson, Arizona • Los Angeles, California • Sacramento, California + 12 more

Conditions: Rett Syndrome
Interventions: fenfluramine hydrochloride, Placebo; Drug · Other
Lead sponsor: UCB BIOSCIENCES, Inc.; Industry
Eligibility: 5 Years to 35 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 8
States / cities: Little Rock, Arkansas • Miami, Florida • Orlando, Florida + 5 more

Conditions: Catheterization, Peripheral
Interventions: ultrasound, standard technique for venipuncture; Device
Lead sponsor: University of California, Davis; Other
Eligibility: Up to 7 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Bipolar Disorder
Interventions: Group Psychotherapy; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Elevated Serum PSA
Interventions: Ibuprofen 400 mg; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 80 Years · Male only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Chicago, Illinois • Albany, New York • Hershey, Pennsylvania

Conditions: TBI (Traumatic Brain Injury), Depressive Disorder, Major, Clinical Depression, Mood Depressed, Physical Inactivity
Interventions: InMotion; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 64 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Child Abuse, Child Neglect, Risk Behavior, Delinquency, Mental Health Impairment, Substance Use, Educational Problems, Adolescent Development, Adolescent Behavior, Sexual Behavior, Child Maltreatment
Interventions: FHF-T; Behavioral
Lead sponsor: University of Denver; Other
Eligibility: 13 Years to 16 Years
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2044
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Mild to Moderate Persistent Asthma
Interventions: Activation Energy Serum; Dietary Supplement
Lead sponsor: California Allergy and Asthma Medical Group, Inc.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Subarachnoid Hemorrhage, Subdural Hematoma, Traumatic Brain Injury, Ischemic Stroke, Fever, Intracerebral Hemorrhage
Interventions: Bromocriptine 5 MG, Acetaminophen 650 MG; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 100 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Pneumococcal Infections
Interventions: 13 valent Pneumococcal Conjugate Vaccine, 23vPS; Biological
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer; Industry
Eligibility: 70 Years and older
Enrollment: 938 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 51
States / cities: Mobile, Alabama • Mesa, Arizona • Fountain Valley, California + 43 more

Conditions: PTSD
Interventions: Cognitive Processing Therapy, Relaxation Training; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Angina
Interventions: Febuxostat, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 21
States / cities: Carmichael, California • Fresno, California • Irvine, California + 18 more

Conditions: Muscle Spasticity, Stroke
Interventions: MyoRegulator® device; Device
Lead sponsor: PathMaker Neurosystems Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Cambridge, Massachusetts • Charlestown, Massachusetts

Search by objective public record fields.

Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo

Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation

Study to Determine the Digestive and Physiological Effects of an Extract From Bran in Healthy Men and Women

Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion

Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea

Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS

PTSD Prevention Using Oral Hydrocortisone

A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled Asthma

A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome

Ultrasound Assisted Peripheral Venous Access in Young Children

A Pilot Study of Psychodynamic Psychotherapy for Bipolar Disorder

Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen

InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI

Fostering Healthy Futures for Teens: An RCT

Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma.

Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury

Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)

Exploring Mechanisms of Massed Cognitive Processing Therapy

Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina

Study Evaluating MyoRegulator® Treatment in Post-Stroke Upper Limb Spasticity